Verified stock metrics
TransCode Therapeutics Key Stock Metrics
Direct answer
TransCode Therapeutics has 6 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 6, 2026.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $29.29M
- Return on equity
- -59.28%
- Dividend yield
- 0%
- 52-week price range
- $1.52 to $20.99
- Profit margin
- 0%
- Debt-to-equity ratio
- 0.47%
Explore related company data
View TransCode Therapeutics's market capitalizationView TransCode Therapeutics's return on equityView TransCode Therapeutics's dividend yieldView TransCode Therapeutics's 52-week price rangeView TransCode Therapeutics's profit marginView TransCode Therapeutics's debt-to-equity ratioReturn to TransCode Therapeutics profile